Searchable abstracts of presentations at key conferences in endocrinology

ea0099p518 | Pituitary and Neuroendocrinology | ECE2024

Long-term pharmacotherapy of giant prolactinomas

Hana Vaclav , Vaněčkova Manuela , Krsek Michal , Kosak Mikulaš , Ježkova Jana , Hana jr. Vaclav , Krausova Adela , Diblik Pavel , Kuthan Pavel , Sklenka Petr , Netuka David , Masopust Vaclav , Majovsky Martin , Liščak Roman

Giant prolactinomas (GPs) are prolactin secreting pituitary adenomas (PitNETs) ≥4 cm, usually with prolactinaemia over 1000 mg/l and without co-secretion of other hormones. Aims: evaluation of long term treatment of GPs, the effect of D2 agonists and of different doses on prolactinaemia, tumour shrinkage and complications.Patients and methods: 33 patients (27 males, 82%) diagnosed with GP in our department between 1997 - 2020...

ea0099p158 | Thyroid | ECE2024

Subacute thyroiditis in the SARS-Cov-2 era: a multicenter prospective study

Sueri Roberta , De Vincentis Sara , Loiacono Simona , Zanni Eleonora , Laura Monzani Maria , Santi Daniele , Muller Ilaria , Di Marco Francesco , Crivicich Erica , Pagotto Uberto , Cecchetti Carolina , Tucci Lorenzo , Simoni Manuela , Brigante Giulia

Introduction: Several cases of subacute thyroiditis (SAT) have been described in patients with SARS-CoV-2. However, no prospective data about follow-up in SARS-CoV-2-related SAT are known.Aim: The characterization of clinical peculiarities and response to medical treatment of SAT cases, correlating to virus exposure, ascertained with antibody (Ab) dosage.Methods: A prospective, 3-years, multicentre study was conducted, enrolling pa...

ea0035p1149 | Thyroid Cancer | ECE2014

Prognostic significance of TERT promoter mutations in follicular cell-derived thyroid carcinomas

Melo Miguel , da Rocha Adriana Gaspar , Vinagre Joao , Batista Rui , Peixoto Joana , Celestino Ricardo , Salgado Catarina , Eloy Catarina , Lima Jorge , Amaro Teresina , Lobo Claudia , Moura Margarida , Cavaco Branca , Leite Valeriano , Cameselle-Teijeiro Jose Manuel , Carrilho Francisco , Carvalheiro Manuela , Maximo Valdemar , Sobrinho-Simoes Manuel , Soares Paula

Context: Telomerase promoter mutations (TERT) were recently described in follicular cell-derived thyroid carcinomas (FCDTC) and seem to be more prevalent in aggressive cancers.Objectives: We aimed to evaluate the frequency of TERT promoter mutations in thyroid lesions and to investigate the prognostic significance of such mutations in a large cohort of patients with differentiated thyroid carcinomas (DTC).<p class="abstext"...

ea0090p381 | Endocrine-related Cancer | ECE2023

Gender related differences in patients with carcinoid syndrome: new insights from a multicenter retrospective study

Grazia Tarsitano Maria , Altieri Barbara , Grossrubatscher Erika , Minotta Roberto , Zamponi Virginia , Albertelli Manuela , Appetecchia Marialuisa , Pia Brizzi Maria , Vittoria Davi Maria , Fanciulli Giuseppe , Giannetta Elisa , Guarnotta Valentina , La Salvia Anna , Lania Andrea , Lavezzi Elisabetta , Malandrino Pasqualino , Mazzilli Rossella , Modica Roberta , Pia Anna , Prinzi Natalie , Pusceddu Sara , Razzore Paula , Zanata Isabella , Chiara Zatelli Maria , Isidori Andrea , Maria Colao Anna , Faggiano Antongiulio , Maddalena Ruggeri Rosaria

The incidence of Neuroendocrine Neoplasm (NEN) and related carcinoid syndrome (CS) increased markedly in recent decades, and women appear to be more at risk than men. As per other tumors, gender may be relevant in influencing the clinical and prognostic characteristics. Unfortunately, there are no studies designed to answer this question in the literature. The present multicentric study was designed to evaluated gender differences, if any, in clinical presentation and outcomes...

ea0067o48 | Oral Presentations | EYES2019

Real-world management of male idiopathic infertility in indication for FSH treatment: a multicenter, longitudinal, observational cohort study (open registry)

De Vincentis Sara , Rago Rocco , Dal Lago Alessandro , Lombardo Francesco , Pallotti Francesco , Cargnelutti Francesco , Pivonello Rosario , Mazzella Marco , De Angelis Cristina , Rampini Mariarita , Alfano Patrizia , Balercia Giancarlo , Salvio Gianmaria , Cutini Melissa , Elisabetta Coccia Maria , Badolato Laura , Orlandi Giulia , Calogero Aldo E. , Condorelli Rosita A. , Mongioi Laura M. , Allegra Adolfo , Marino Angelo , Iannantuoni Nicola , Zullo Clelia , Capuozzo Caterina , Simoni Manuela , Santi Daniele

Objective: The management of male idiopathic infertility is challenging. The Italian Medicines Agency (AIFA) note 74 regulates the empirical administration of follicle-stimulating hormone (FSH), although its application in clinical practice remain conflicting. The aim was to explore the management of male idiopathic infertility and to assess the actual use of FSH.Methods: A multicenter longitudinal prospective observational study (open-registry), involvi...

ea0099ep638 | Calcium and Bone | ECE2024

Evaluation of Irisin levels in a group of young patients with Cerebral Palsy compared with healthy matched controls

Saponaro Federica , Sgandurra Giuseppina , Beani Elena , Paolicelli Paola , Brunori Elena , Tinelli Francesca , Filogna Silvia , Cioni Giovanni , Chiellini Grazia , Polini Beatrice , Ricardi Caterina , Pignataro Patrizia , Colucci Silvia , Dicarlo Manuela , Zerlotin Roberta , Colaianni Graziana , Comberiati Pasquale , Baroncelli Gianpiero , Gamborino Agnese , Saba Alessandro , Grano Maria

Introduction: Cerebral palsy (CP) is the most common chronic disability in childhood, burden by motor, sensation, cognition, feeding and communication impairment. A serious concern in children with CP is bone/muscle health deterioration, which negatively impacts the already reduced quality of life (QoL). Irisin is a myokine secreted by contracting muscle, which mediates beneficial effects on several targets, including brain. The aim of this pilot study was to evaluate serum le...

ea0044ep99 | (1) | SFEBES2016

Vomiting as harbinger for Graves’ disease

Bejinariu Emanuela , Banerjee Ritwik , Soo Shiu-Ching

Introduction: Isolated vomiting is a rare often forgotten presentation of Graves’s disease and can lead to delayed diagnosis. Multiple case reports quote vomiting in thyrotoxicosis co-presenting with Addisonian crisis, diabetic ketoacidosis or with abnormal liver function and jaundice. Another common association is hyperemesis gravidarum. Vomiting in paraneoplastic hyperthyroidism occurs through a similar mechanism of beta-HCG secretion, mainly related to germ-line tumour...

ea0034p32 | Clinical biochemistry | SFEBES2014

Limitations of dexamethasone suppression tests for Cushing's disease: a reminder!

Bejinariu Emanuela , Soo Shiu-Ching , Banerjee Ritwik

Case history: A 70 years old man with longstanding resistant hypertension on five antihypertensive agents, type two diabetes and raised BMI at 35.6 was referred to the endocrinology clinic for exclusion of possible Cushing’s disease. Clinically he had truncal obesity with plethoric face but no telangiectasia, easy bruising, purple striae or myopathy.Investigations: Endocrine examinations revealed normal 24 h urine free cortisol levels on two separat...

ea0090p623 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Hirata disease: a rare cause of hypoglycemia

Rusu Eva , Stanoiu- Pinzariu Oana , Emanuela Georgescu Carmen

Introduction: Hirata disease (or Insulin autoimmune syndrome) is characterized by the presence of high concentrations of insulin autoantibodies leading to hyperinsulinemic hypoglycemia in individuals with no history of prior exposure to exogenous insulin. Etiopathogenesis is not completely elucidated, it’s considered to result from the interaction of genetic predisposition and environmental triggers such as: medications (methimazole, carbimazole, alpha-lipoic acid, captop...

ea0090p492 | Thyroid | ECE2023

Resistance to Thyroid Hormone Beta in a 12-Year-Old Patient: Clinical, Laboratory, and Molecular Characteristics

Lozovanu Vera , Alina Silaghi Cristina , Emanuela Georgescu Carmen

Background: Resistance to thyroid hormone beta (RTHβ) is an inherited syndrome of reduced tissue responsiveness to thyroid hormones (THs). It is driven in 85% of cases by mutations in the thyroid hormone receptor beta (THRb). The estimated incidence is 1:40.000 to 1:19.000 live births. We report the clinical, laboratory, and genetic analysis of a patient with this disorder.Case report: A 12-year-old boy with a history of Attention-Deficit/H...